Stem cell therapy in Istanbul, planned around your diagnosis

Mesenchymal stromal cells from Wharton's jelly, the gelatinous tissue inside a donated umbilical cord. It is a young perinatal source, the cells expand readily in culture, and our team can show you the documentation behind the batch prepared for you: donor consent and infectious-disease screening, identity testing, sterility and endotoxin results, viable cell count, the certificate of analysis, and the storage and transport record.

Autoimmune and inflammatory conditions, joint and soft-tissue problems, neurological diagnoses and metabolic disease. The research behind each one differs, so our medical team reviews your records and tells you plainly whether we think your case is a fit for treatment.

By intravenous infusion, by intrathecal administration, by intranasal delivery, or by an injection guided to a specific joint or tendon. The route follows the treatment goal, and it is named in your plan together with the number of sessions and the monitoring involved.

You send your confirmed diagnosis, recent reports and imaging, current medications, prior treatment and allergies. Our medical team reviews them and replies in writing with an assessment of suitability, the pathway we would propose, and the questions we still need answered.

There is no single timeline that fits every condition, so we set review points instead of promising one. Before treatment our team records your baseline and agrees which measures will be repeated, and at each review we compare the two and discuss what to do next.

Send your confirmed diagnosis, recent reports and imaging, current medications and medical history to our patient coordination team. Our medical team reviews suitability case by case and tells you in writing whether this pathway fits your situation, and what it would involve.

It depends on the plan our medical team proposes: the procedure, the route, the monitoring, your mobility and the follow-up all affect it. Your written schedule states the number of days before you book flights or accommodation.

No medical treatment is free of risk, and we are direct about that. Our team reduces the risks that can be reduced: screened donor material, batch testing before release, administration by a physician in a clinical setting, monitoring during and after the procedure, and a written account of the side effects and contraindications that apply to your plan.

Your plan states a therapeutic goal and how it will be measured, not a promised outcome. Our medical team explains what change would be meaningful in your case, when it will be reviewed, and what we would do next if that review shows no benefit.

Pricing is case-specific: the material, the preparation and dose, the route, the number of sessions, the monitoring and any travel services all affect it. Our patient coordination team sends an itemized written estimate so you can see what each part of the plan costs before you commit.

Your estimate lists the medical review, tests, the procedure itself, monitoring, medications, airport transfers, accommodation arrangements, written discharge information and follow-up as separate lines, so you can see what is included and what is not.